Showing 15,041 - 15,060 results of 101,553 for search '(( 5 ht decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.58s Refine Results
  1. 15041

    Image_5_COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective.TIF by Satoshi Nishiwaki (560641)

    Published 2021
    “…Similarly, the mean percentage change of reported results for each month in 2019 and 2020 was −5.1%, with the maximum of −27.4% observed in July 2020. …”
  2. 15042
  3. 15043
  4. 15044
  5. 15045

    S1 File - by Phyo Zin Winn (16733843)

    Published 2023
    “…PubMed (Public/Publisher MEDLINE), PubMed Central and EMBASE (Excerpta Medica Database) databases were conveniently selected and Boolean search commands were used for a comprehensive literature search. Five core search terms were "effects of treatments", " COVID-19-related olfactory dysfunction", "corticosteroids", "treatments" and "interventions". …”
  6. 15046

    Characteristics of the included studies. by Phyo Zin Winn (16733843)

    Published 2023
    “…PubMed (Public/Publisher MEDLINE), PubMed Central and EMBASE (Excerpta Medica Database) databases were conveniently selected and Boolean search commands were used for a comprehensive literature search. Five core search terms were "effects of treatments", " COVID-19-related olfactory dysfunction", "corticosteroids", "treatments" and "interventions". …”
  7. 15047

    The frame of review question. by Phyo Zin Winn (16733843)

    Published 2023
    “…PubMed (Public/Publisher MEDLINE), PubMed Central and EMBASE (Excerpta Medica Database) databases were conveniently selected and Boolean search commands were used for a comprehensive literature search. Five core search terms were "effects of treatments", " COVID-19-related olfactory dysfunction", "corticosteroids", "treatments" and "interventions". …”
  8. 15048
  9. 15049
  10. 15050

    Trends in food consumption of schoolchildren from 2nd to 5th grade: a panel data analysis by Luciana Jeremias PEREIRA (10470669)

    Published 2021
    “…<div><p>ABSTRACT Objective To identify trends in food consumption among schoolchildren (2nd-5th grades) from public schools in the city of Florianópolis, Brazil, in a period of three years. …”
  11. 15051
  12. 15052

    Selective C−H Activation of Haloalkanes using a Rhodiumtrispyrazolylborate Complex by Andrew J. Vetter (2349535)

    Published 2009
    “…By comparing the kinetic stabilities of a series of 1-chloroalkane activation products (C<sub>1</sub>−C<sub>5</sub>), it was found that the chlorine substituent dramatically decreases reductive elimination rates as the substitution is closer to the metal center. …”
  13. 15053
  14. 15054

    E1784K accelerates a component of slow inactivation with 1-10s time constants. by Colin H. Peters (4430245)

    Published 2017
    “…<p><b>(A1 and A2)</b> Sample inward sodium currents recorded after 20ms to 60s repolarization pulses to -90mV following either a 500ms or 64s depolarization to -30mV. …”
  15. 15055
  16. 15056
  17. 15057

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  18. 15058

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  19. 15059

    DataSheet_1_Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model.pdf by Ikechukwu B. Jacob (18253300)

    Published 2024
    “…Pre-incubation of SARS-CoV-2 (Delta) with human SP-A inhibited virus binding and entry and reduced viral load in human lung epithelial cells, evidenced by the dose-dependent decrease in viral RNA, nucleocapsid protein (NP), and titer (p<0.01). …”
  20. 15060